Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
收藏官方服务：
资源简介：
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
应用场景：
创建时间：
2021-03-08
相关数据集
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3–4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing
NIAID Data Ecosystem80
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A
Hepatitis C virus (HCV) is a major cause of end-stage liver diseases. With 3–4 million new HCV infections yearly, a vaccine is urgently needed. A better understanding of virus escape from neutralizing
Figshare2017-03-20 更新30
Delta-Omicron recombinant escapes therapeutic antibody neutralization (raw sequence reads)
A novel Delta-Omicron SARS-CoV-2 recombinant was identified in an unvaccinated, immunosuppressed kidney transplant recipient treated with monoclonal antibody Sotrovimab. The recombination breakpoint i
NIAID Data Ecosystem20
Linear regression results with censored data.
Because SARS-CoV-2 constantly mutates to escape from the immune response, there is a reduction of neutralizing capacity of antibodies initially targeting the historical strain against emerging Variant
Figshare2023-08-07 更新40
Median fold reduced neutralization susceptibility of 6 variants and 6 spike mutations to 12 mAbs in advanced clinical development 1 .
Median fold reduced neutralization susceptibility of 6 variants and 6 spike mutations to 12 mAbs in advanced clinical development1.
NIAID Data Ecosystem30
